RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer

Stock Information for RxSight Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About RxSight Inc.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST
RxSight, Inc. to Present at the Piper Sandler Healthcare Conference
RxSight, Inc. Reports Third Quarter 2025 Financial Results
RxSight, Inc. to Report Third Quarter 2025 Financial Results on November 5, 2025
RxSight, Inc. to Feature Live Learning Sessions at American Academy of Ophthalmology 2025 Annual Meeting

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.